(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6.55%14.2B | 47.33%44.29B | -6.47%13.33B | -9.69%30.06B | -34.44%14.25B | -31.09%33.28B | 3.20%21.74B | -6.14%48.3B | -20.85%21.07B | 49.75%51.46B |
Operating income | 6.55%14.2B | 47.33%44.29B | -6.47%13.33B | -9.69%30.06B | -34.44%14.25B | -31.09%33.28B | 3.20%21.74B | -6.14%48.3B | -20.85%21.07B | 49.75%51.46B |
Cost of sales | 15.77%-11.29B | -18.02%-42.7B | 4.59%-13.4B | -22.00%-36.18B | 28.19%-14.05B | 31.02%-29.66B | -9.14%-19.56B | -10.27%-42.99B | 11.50%-17.93B | -48.23%-38.99B |
Operating expenses | 15.77%-11.29B | -18.02%-42.7B | 4.59%-13.4B | -22.00%-36.18B | 28.19%-14.05B | 31.02%-29.66B | -9.14%-19.56B | -10.27%-42.99B | 11.50%-17.93B | -48.23%-38.99B |
Gross profit | 4,013.43%2.91B | 125.94%1.59B | -136.64%-74.42M | -268.66%-6.12B | -90.66%203.11M | -31.70%3.63B | -30.73%2.18B | -57.42%5.31B | -50.63%3.14B | 54.68%12.48B |
Selling expenses | 66.85%-116.9M | 40.60%-577.15M | 51.89%-352.61M | 24.66%-971.65M | -14.42%-732.91M | -2.44%-1.29B | -30.06%-640.54M | -5.00%-1.26B | 10.39%-492.51M | -5.46%-1.2B |
Administrative expenses | 0.02%-360.4M | 33.63%-670.05M | 52.03%-360.49M | 15.75%-1.01B | -18.97%-751.48M | 25.27%-1.2B | 8.48%-631.68M | -8.40%-1.6B | 7.22%-690.22M | -10.29%-1.48B |
Revaluation surplus | -163.29%-38.31M | 113.08%96.66M | 104.23%60.53M | -2,191.36%-739.01M | -3,687.06%-1.43B | 82.50%-32.25M | 61.27%-37.76M | -471.02%-184.33M | -223.90%-97.5M | -85.24%49.68M |
-Changes in the fair value of investment property | -163.29%-38.31M | 113.08%96.66M | 104.23%60.53M | -2,191.36%-739.01M | -3,687.06%-1.43B | 82.50%-32.25M | 61.27%-37.76M | -471.02%-184.33M | -223.90%-97.5M | -85.24%49.68M |
Impairment and provision | ---- | -233.61%-2.63B | ---- | -17,237.43%-788.32M | ---- | --4.6M | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---- | -233.61%-2.63B | ---- | -17,237.43%-788.32M | ---- | --4.6M | ---- | ---- | ---- | ---- |
Special items of operating profit | -195.76%-36.54M | 16.90%-820.29M | 104.65%38.16M | -185.27%-987.1M | -296.55%-820.93M | 71.24%1.16B | -2.70%417.68M | 126.74%676.03M | 472.39%429.28M | 141.49%298.15M |
Operating profit | 442.63%2.36B | 71.61%-3.01B | 80.50%-688.83M | -567.60%-10.62B | -375.27%-3.53B | -22.81%2.27B | -43.96%1.28B | -71.01%2.94B | -56.15%2.29B | 67.77%10.14B |
Financing income | -50.60%24.95M | -72.53%76.48M | -70.64%50.51M | -62.20%278.39M | -54.07%172.03M | -59.27%736.49M | 13.94%374.58M | 623.56%1.81B | 148.62%328.75M | 2.82%249.91M |
Financing cost | -5.34%-1.51B | -32.17%-2.76B | -16.27%-1.43B | -228.39%-2.09B | -1,152.13%-1.23B | -38.48%-636.27M | 64.23%-98.49M | 27.01%-459.48M | 11.87%-275.35M | -17.67%-629.48M |
Special items of earning before tax | 398.44%90.99M | 21.70%625.82M | -95.23%18.25M | 402.96%514.22M | 449.73%382.32M | -83.28%102.24M | -49.53%69.55M | -31.73%611.46M | -85.07%137.8M | --895.66M |
Earning before tax | 147.01%965.57M | 57.42%-5.07B | 51.22%-2.05B | -581.76%-11.91B | -358.54%-4.21B | -49.55%2.47B | -34.34%1.63B | -54.02%4.9B | -58.41%2.48B | 60.13%10.66B |
Tax | -114.49%-885.59M | -236.21%-1.77B | -14.84%-412.89M | 29.23%-527.83M | 38.89%-359.54M | 46.98%-745.87M | 29.55%-588.35M | 70.49%-1.41B | 65.97%-835.18M | -49.62%-4.77B |
After-tax profit from continuing operations | 103.24%79.98M | 44.96%-6.85B | 46.03%-2.47B | -820.43%-12.44B | -539.30%-4.57B | -50.59%1.73B | -36.77%1.04B | -40.71%3.49B | -53.12%1.65B | 69.78%5.89B |
Earning after tax | 103.24%79.98M | 44.96%-6.85B | 46.03%-2.47B | -820.43%-12.44B | -539.30%-4.57B | -50.59%1.73B | -36.77%1.04B | -40.71%3.49B | -53.12%1.65B | 69.78%5.89B |
Minority profit | 523.85%2.01B | 23.03%-927.58M | -235.90%-474.4M | -379.17%-1.21B | -139.68%-141.23M | -59.52%431.68M | -51.71%355.89M | -60.93%1.07B | -49.50%737.07M | 135.74%2.73B |
Profit attributable to shareholders | 3.10%-1.93B | 47.31%-5.92B | 55.02%-1.99B | -967.52%-11.23B | -747.07%-4.43B | -46.66%1.3B | -24.65%684.51M | -23.27%2.43B | -55.69%908.43M | 36.77%3.16B |
Basic earnings per share | 2.54%-1.15 | 47.23%-3.52 | 55.13%-1.18 | -966.23%-6.67 | -741.46%-2.63 | -46.15%0.77 | -22.64%0.41 | -23.53%1.43 | -55.46%0.53 | 35.51%1.87 |
Diluted earnings per share | 2.54%-1.15 | 47.23%-3.52 | 55.13%-1.18 | -966.23%-6.67 | -741.46%-2.63 | -45.77%0.77 | -22.64%0.41 | -23.24%1.42 | -55.08%0.53 | 35.04%1.85 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data